Fibrocell Science Inc
Change company Symbol lookup
Select an option...
FCSC Fibrocell Science Inc
WPG Washington Prime Group Inc
VIVC Vivic Corp
CBRL Cracker Barrel Old Country Store Inc
BA Boeing Co
MSFT Microsoft Corp
GRPN Groupon Inc
JPM JPMorgan Chase & Co
BIDU Baidu Inc
PJET Priority Aviation Inc
Go

Health Care : Biotechnology | Small Cap ValueCompany profile

Fibrocell Science, Inc. is an autologous cell and gene therapy company. The Company is focused on discovering and developing localized therapies for diseases affecting the skin, connective tissue and joints. Its product candidate, azficel-T, is in development to treat patients suffering from vocal cord scarring that is either idiopathic or age-related. It is investigating the indication in a Phase II clinical trial. Its gene-therapy product candidate, FCX-007, is in pre-clinical development for the treatment of recessive dystrophic epidermolysis bullosa. Its gene-therapy product candidate, FCX-013, is in pre-clinical development for the treatment of linear scleroderma. Its product, LAVIV (azficel-T), is indicated for the improvement of the appearance of moderate to severe nasolabial fold wrinkles in adults. A third gene-therapy program is focused on the treatment of arthritis. Its product, LAVIV (azficel-T), is focused on improving the appearance of nasolabial fold wrinkles in adults.

Closing Price
$2.05
Day's Change
-0.1899 (-8.48%)
Bid
--
Ask
--
B/A Size
--
Day's High
2.22
Day's Low
2.02
Volume
(Light)
Volume:
428,167

10-day average volume:
3,677,092
428,167
  • Prev Close
    2.24
  • Today's Open
    2.22
  • Day's Range
    2.02-2.22
  • Avg Vol (10-day)
    3.7M
  • Last (time)
    3:52p ET 04/22/19
  • Last (size)
    196
  • 52-Wk Range
    1.45 - 5.17
    LowHigh
  • (05/25/18 - 12/31/18)
    41.39%
  • 100.5%
  • Market Cap
    20.0M
  • Shares Outstanding
    9.8M
  • -1.56
  • --
  • No dividend
  • Ex-dividend
    No dividend
  • 1.6
  • 27.45
  • (% of float 03/29/19)
    14.70

Earnings Calendar and Events Data provided by |Terms of Use| © 2019 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2019. All rights reserved.